Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label clozapine trial for severe disruptive behavior in adolescents with autism spectrum disorder
RBR-54j3726Phase 4Recruiting
- Sponsor
- Hospital de Clínicas de Porto Alegre
- Start
- Apr 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of clozapine in Autism Spectrum Disorder (ASD), sponsored by Hospital de Clínicas de Porto Alegre. Primary endpoint: Change in Aberrant Behavior Checklist Irritability subscale score. Started Apr 2022; status: recruiting.
02
Drugs
clozapine
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on RBR-54j3726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-54j3726.